Course Catalog
Browse our full catalog of continuing education courses and events
Browse Courses & Events
Hot Seat: Which Agent, and When? Integrating Next-Generation Endocrine Strategies Into HR+/HER2– Breast Cancer Management
Ruta D. Rao, MD; Kamel Abou Hussein, MD; Jame Abraham MD, FACP; Paolo Tarantino, MD, PhD
Tumor Board: Evolving Immunotherapy Strategies for Stage I-III NSCLC
Tina Cascone, MD, PhD; Puneeth Iyengar, MD, PhD; Paula A. Ugalde Figueroa, MD
Cases and Conversations: Adopting New Treatment Strategies in Polycythemia Vera and Essential Thrombocythemia
Gabriela Hobbs, MD; Rami Komrokji, MD; Douglas A. Tremblay, MD
Cases and Conversations: Optimizing Oral SERD-Based Therapy After CDK4/6 Inhibition in HR+/HER2– MBC
Virginia Kaklamani, MD, DSc; Antonio Giordano, MD, PhD; Nadia Harbeck, MD, PhD; Sarah Sammons, MD
Medical Crossfire®: Closing Clinical Practice Gaps in Hepatobiliary Cancer With Emerging Immunotherapies and Delivery Innovations
Ghassan Abou-Alfa, MD, MBA; Riad Salem, MD, MBA; Rachna Shroff, MD, MS, FASCO; Arndt Vogel, MD, PhD
Live Tumor Board: Exploring Novel Targets and Breakthrough Treatment Strategies in Extrapulmonary Neuroendocrine Carcinomas
Aman Chauhan, MD, MBBS; Jonathan Strosberg, MD; Sylvia L. Asa, MD, PhD
Practical Strategies for Monitoring and Managing Toxicities With Novel Therapies for HER2-Positive Gastroesophageal Adenocarcinoma
Samuel J. Klempner, MD, FASCO; Christian Baglini, MS, AGNP-BC; Jonathan N. Glickman, MD, PhD
Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – New York
Lori A. Leslie, MD; Bachar Samra, MD
Medical Crossfire®: DLL3-Directed Therapies in Small Cell Lung Cancer—A Nursing-Centered Approach to a New Era of Care
Alissa J. Cooper, MD; Kelly Goodwin, NP; Stephanie J. McDonald, MSN, FNP-BC, AOCNP; Rebecca W. Repet...
Oncology Town Hall: Updates From Berlin: Oral SERDs in HR+/HER2– Metastatic Breast Cancer—What the Latest Data Really Tell Us
Hope S. Rugo, MD, FASCO; Fabrice André, MD, PhD; Heather McArthur, MD, MPH; Nadia Harbeck, MD
Medical Crossfire®: Turning Therapeutic Innovation Into Practice—Personalizing Care in Multiple Myeloma
Mohamad Mohty, MD, PhD; Shaji K. Kumar, MD; Suzanne Lentzsch, MD, PhD; Philippe Moreau, MD
Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – Arkansas
Lori A. Leslie, MD; Alex Mejia, MD
Show Me the Data®: Evolving Standards and New Frontiers in Ovarian Cancer
Ursula A. Matulonis, MD; Bradley J. Monk, MD, FACS, FACOG; Ritu Salani, MD, MBA; Oladapo Yeku, MD, P...
Cases and Conversations®: Advancing Diagnosis and Long-Term Management of CIDP
Karissa Gable, MD; Jeffrey Allen, MD; Suraj Muley, MD, FAAN
Live Tumor Board: Translating Biomarker Insights and Therapeutic Advances Into Endometrial Cancer Practice
Kathleen N. Moore, MD, MS, FASCO; Ritu Salani, MD, MBA; Casey Cosgrove, MD; Ebony R. Hoskins, MD, FA...
The New DED Toolkit: Innovative Therapies Reshaping Dry Eye Management
Laura M. Periman, MD; Kristin Barnes, OD; Selina McGee, OD, FAAO, Dipl ABO; Neda Shamie, MD
Primary Care Playbook: Advancing COVID-19 Prophylaxis in Community Practice
Chuck Vega, MD; Stefan Gravenstein MD, MPH
Tumor Board: Clinical Integration of Molecular Profiling in Glioma—Transforming the Use of Targeted Therapy
Vinay K. Puduvalli, MD; Manmeet Ahluwalia, MD, MBA; Ashley S. Margol, MD, MS
Cases and Conversations™: Redefining Treatment Pathways in Low-Grade Serous Ovarian Cancer
Rachel N. Grisham, MD; David M. Gershenson, MD; Ursula Matulonis, MD; David M. O’Malley, MD
Searching for Silence: Corneal Sensitivity Testing in NK
Francis Mah, MD; Amy Nau, OD , FAAO, Dipl. CCLRT
PER® Postgame™: Addressing the Unmet Medical Needs of Patients with Psoriasis—Summarizing the Latest Advancements in Oral Therapy
Jason E. Hawkes, MD, MS; Christopher G. Bunick, MD, PhD
Advancing Presbyopia Care: Patient-Centered Strategies for Pharmacologic Management
Brian Szabo, DO; Nick Bruns, OD, FAAO
Community Practice Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma
Lori A. Leslie, MD; Krish Patel, MD
From Numbers to Navigation: Translating Data From Diabetes Technologies into Optimized Decision-Making
Diana Isaacs, PharmD, BCACP, CDCES, BC-ADM, FADCES, FCCP; Robert H. Eckel, MD; Javier Morales, MD, F...
Live Tumor Board: Multidisciplinary Strategies to Prevent and Manage ADC-Associated Pulmonary Toxicities in Ovarian Cancer
Kathleen N. Moore, MD, MS, FASCO; Rachel N. Grisham, MD; Rohit Gupta, MD; Maida Hafiz, MD
From Data to Decisions: Applying the Latest Evidence for New Targeted Therapies in HER2-Positive Gastroesophageal Adenocarcinoma
Pashtoon Kasi, MD, MS; Elizabeth Conner, MD; Simona De Michele, MD
Join Us at The Ophthalmology Meeting This October in New Orleans
October 9-11, 2026
Rapid Reviews in Retina™: Emerging Updates from Winter 2026 – Addressing the Wealth of New Data in Treatments for nAMD, DME, and RVO
Judy E. Kim, MD, FARVO, FASRS; Prethy Rao, MD, MPH, FACS
AREDS3 and Beyond: The Scientific Basis for B Vitamin Nutritional Supplementation in AMD
September 13, 2026
Show Me the Data®: From Mutation to Action — KRAS as a Therapeutic Target in PDAC
E. Gabriela Chiorean, MD; Tanios S. Bekaii-Saab, MD; Mitesh Borad, MD; Christopher Lieu, MD
Clinical Crossroads™: Delayed Identification of Hypercortisolism – What Are the Risks?
Yehuda Handelsman, MD, FACP, FNLA, FASPC, FAHA, MACE
Optimizing HER2 Testing in Gastroesophageal Adenocarcinoma: Laying the Foundation for Targeted Therapy
Yelena Y. Janjigian, MD; Michal F. Segal, BSN, OCN
Oncology Town Hall: Translating the Latest Updates Into the Care of Patients With AML in Community Practice
Eunice Wang, MD; Hetty Carraway, MD, MBA; Naval G. Daver, MD
Cases and Conversations™: Integrating PSMA-Directed Radioligand Therapy in Prostate Cancer Care: Recent Data and Evolving Strategies
Mary-Ellen Taplin, MD; Jeremie Calais, MD, PhD; Himanshu Nagar, MD, MS
Lupus Nephritis Postgame: Takeaways from our Expert Faculty
Shivani Garg, MD, PhD; Samir V. Parikh, MD, FASN
Show Me the Data™: Post-TKI Sequencing in EGFR-Mutated NSCLC—Optimizing Current Strategies and Preparing for New Treatment Modalities
Christine M. Lovly, MD, PhD, FASCO; Xiuning Le, MD, PhD; Hossein Borghaei, DO, MS; Lyudmila Bazhenov...
Medical Crossfire® — From Diagnostic Dilemmas to Potential Treatment Breakthroughs: Exploring Novel Targets for Extrapulmonary Neuroendocrine Carcinomas
David S. Klimstra, MD; Danielle A. Hutchings, MD; Nancy M. Joseph, MD, PhD; Jonathan Strosberg, MD
Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Cancer
Sanja Dacic, MD, PhD; Soo-Ryum (Stewart) Yang, MD; Isabel Preeshagul, DO, MBS
Community Practice Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer
Neil M. Iyengar, MD; Sara M. Tolaney, MD, MPH
Burst CME Expert Illustrations & Commentaries™: Breaking Down DLL3-Targeting Immune Cell Effector Agents in SCLC
Jacob Sands, MD; Anne Chiang, MD, PhD
Collaborating Across the Continuum®: Tying the Threads: Screening, Referrals, and Optimized Treatments in MASLD/MASH
Nancy Reau, MD; Conan Tu, MD; Sonal Kumar, MD, MPH